Globomycin

Globomycin is a lipopeptide antibiotic and a signal peptidase II (LspA) inhibitor. Globomycin inhibits processing of the prolipoprotein by binding irreversibly to the peptidase. Globomycin has toxic for the mollicute Spiroplasma melliferum with a MIC in the range 6.25-12.5 μM[1][2].

Product Specifications

CAS Number

[67076-74-8]

UNSPSC

12352209

Target

Antibiotic; Bacterial

Type

Peptides

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/globomycin.html

Purity

99.0

Solubility

10 mM in DMSO

Smiles

CC(C)C[C@@](N(C([C@@H]([C@H](OC(CNC1=O)=O)CCCCCC)C)=O)C)([H])C(N[C@@](C(N[C@H](C(N[C@@]1([H])[C@@H](O)C)=O)CO)=O)([H])[C@H](C)CC)=O

Molecular Formula

C32H57N5O9

Molecular Weight

655.82

References & Citations

[1]Béven L, et al. Inhibition of spiralin processing by the lipopeptide antibiotic globomycin. Curr Microbiol. 1996 Nov;33 (5) :317-22.|[2]Parthasarathy S, et al. Organophosphate Hydrolase Is a Lipoprotein and Interacts with Pi-specific Transport System to Facilitate Growth of Brevundimonas diminuta Using OP Insecticide as Source of Phosphate. J Biol Chem. 2016 Apr 1;291 (14) :7774-85.